EG26922A - Salts of mineral nutrients stabilized with amino acids and/or ammonium salts, products and food supplements that contain them and methods for obtaining - Google Patents

Salts of mineral nutrients stabilized with amino acids and/or ammonium salts, products and food supplements that contain them and methods for obtaining

Info

Publication number: EG26922A
Authority: EG; Egypt
Prior art keywords: salts; obtaining; products; contain; methods
Prior art date: 2004-08-27

Application number

Other languages

English (en)

Inventor

Denis Drapeau

Yen-Tuang Luan

James R Mercer

Wenge Wang

Daniel Lasko

Original Assignee

Wyeth Res Ireland Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-27

Filing date

2007-02-27

Publication date

2014-12-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35500648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG26922(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-02-27 Application filed by Wyeth Res Ireland Ltd filed Critical Wyeth Res Ireland Ltd

2014-12-25 Application granted granted Critical

2014-12-25 Publication of EG26922A publication Critical patent/EG26922A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EGNA2007000222 2004-08-27 2007-02-27 Salts of mineral nutrients stabilized with amino acids and/or ammonium salts, products and food supplements that contain them and methods for obtaining EG26922A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US60537904P	2004-08-27	2004-08-27
PCT/US2005/030439 WO2006026447A2 (fr)	2004-08-27	2005-08-26	Production de tnfr-ig

Publications (1)

Publication Number	Publication Date
EG26922A true EG26922A (en)	2014-12-25

Family

ID=35500648

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EGNA2007000222 EG26922A (en)	2004-08-27	2007-02-27	Salts of mineral nutrients stabilized with amino acids and/or ammonium salts, products and food supplements that contain them and methods for obtaining

Country Status (37)

Country	Link
US (1)	US7300773B2 (fr)
EP (2)	EP1992697B1 (fr)
JP (3)	JP2008511330A (fr)
KR (1)	KR100988451B1 (fr)
CN (2)	CN101061231B (fr)
AR (2)	AR050537A1 (fr)
AT (2)	ATE446376T1 (fr)
AU (1)	AU2005280036B2 (fr)
BR (1)	BRPI0514694B8 (fr)
CA (1)	CA2578138C (fr)
CL (1)	CL2017000577A1 (fr)
CR (2)	CR8998A (fr)
CY (2)	CY1109721T1 (fr)
DE (2)	DE602005020076D1 (fr)
DK (2)	DK1992697T3 (fr)
EC (1)	ECSP077354A (fr)
EG (1)	EG26922A (fr)
ES (2)	ES2341390T3 (fr)
GT (2)	GT200500233A (fr)
HN (1)	HN2005000485A (fr)
HR (2)	HRP20100011T1 (fr)
IL (1)	IL181588A (fr)
MX (1)	MX2007002381A (fr)
MY (1)	MY137803A (fr)
NO (1)	NO344785B1 (fr)
NZ (1)	NZ579208A (fr)
PE (2)	PE20100448A1 (fr)
PL (2)	PL1781802T3 (fr)
PT (2)	PT1992697E (fr)
RS (2)	RS51255B (fr)
RU (1)	RU2458988C2 (fr)
SI (2)	SI1992697T1 (fr)
SV (1)	SV2006002211A (fr)
TW (1)	TWI364458B (fr)
UA (1)	UA89383C2 (fr)
WO (1)	WO2006026447A2 (fr)
ZA (1)	ZA200701672B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI374935B (en)	2004-08-27	2012-10-21	Pfizer Ireland Pharmaceuticals	Production of α-abeta
TWI384069B (zh)	2004-08-27	2013-02-01	Pfizer Ireland Pharmaceuticals	多胜肽之製法
WO2006138181A2 (fr)	2005-06-14	2006-12-28	Amgen Inc.	Preparations de proteines a tamponnage spontane
AR058140A1 (es) *	2005-10-24	2008-01-23	Wyeth Corp	Metodo de produccion proteica utilizando compuestos anti-senescencia
US20070231895A1 (en) *	2005-11-02	2007-10-04	Lee Gene W	Methods for adapting mammalian cells
KR101495549B1 (ko) *	2006-07-13	2015-02-25	와이어쓰 엘엘씨	당단백질의 생산
US8192951B2 (en) *	2006-11-03	2012-06-05	Wyeth Llc	Glycolysis-inhibiting substances in cell culture
CA2668771C (fr) *	2006-11-08	2016-03-15	Wyeth	Milieux concus rationnellement pour une culture cellulaire
RU2009132986A (ru) *	2007-03-02	2011-04-10	Уайт (Us)	Применение меди и глутамата в культуре клеток для производства полипептидов
TW200902708A (en) *	2007-04-23	2009-01-16	Wyeth Corp	Methods of protein production using anti-senescence compounds
JP5576115B2 (ja)	2007-04-26	2014-08-20	中外製薬株式会社	高濃度アミノ酸含有培地を用いた細胞の培養方法
EP2310523B1 (fr) *	2008-04-17	2015-06-10	Wyeth LLC	Procédés de production améliorée de protéines morphogénétiques osseuses
JP2011516086A (ja) *	2008-04-18	2011-05-26	上海中信国健薬業股▲ふん▼有限公司	濃縮培養液及びその使用方法
WO2010016943A2 (fr) *	2008-08-08	2010-02-11	Biogen Idec Ma Inc.	Surveillance des nutriments et contrôle rétroactif pour accroître la production d'un bioproduit
WO2011019619A1 (fr)	2009-08-11	2011-02-17	Genentech, Inc.	Production de protéines dans des milieux de culture cellulaire sans glutamine
CN102770458A (zh) *	2009-12-02	2012-11-07	阿塞勒隆制药公司	用于增加Fc融合蛋白的血清半寿期的组合物和方法
CA2795461C (fr)	2010-04-26	2018-04-24	Novartis Ag	Procede ameliore de culture cellulaire
BR112012027434B1 (pt)	2010-04-26	2020-09-29	Novartis Ag	Processo para produção de um polipeptídeo recombinante compreendendo uma fase de produção
WO2012023085A1 (fr)	2010-08-20	2012-02-23	Wyeth Llc	Culture cellulaire de cellules adaptées exemptes de facteur de croissance
AU2011329053A1 (en)	2010-11-15	2013-06-06	Biogen Inc.	Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography
KR101591671B1 (ko)	2011-04-29	2016-02-04	바이오콘 리서치 리미티드	항체의 이질성을 감소시키는 방법 및 그 항체의 제조방법
EP2718328A4 (fr)	2011-06-08	2014-12-24	Acceleron Pharma Inc	Compositions et procédés pour augmenter la demi-vie sérique
US10493151B2 (en)	2011-10-18	2019-12-03	Coherus Biosciences, Inc.	Etanercept formulations stabilized with sodium chloride
SG11201401562RA (en)	2011-10-18	2014-09-26	Coherus Biosciences Inc	Etanercept formulations stabilized with sodium chloride
CA2852021C (fr) *	2011-10-21	2018-08-28	Pfizer Inc.	Ajout de fer pour ameliorer une culture cellulaire
JP2015509714A (ja) *	2012-02-22	2015-04-02	エヌヴィーアイピープロプライエタリーリミテッド	腫瘍壊死因子レセプター融合タンパク質及び前記タンパク質を使用する方法
JP6271536B2 (ja)	2012-07-09	2018-01-31	コヒラス・バイオサイエンシズ・インコーポレイテッド	肉眼不可視粒子の著しい低減を示すエタネルセプト製剤
AU2013315750B9 (en)	2012-09-11	2018-11-15	Coherus Biosciences, Inc.	Correctly folded etanercept in high purity and excellent yield
US9217168B2 (en)	2013-03-14	2015-12-22	Momenta Pharmaceuticals, Inc.	Methods of cell culture
SG11201507875RA (en)	2013-03-26	2015-10-29	Coherus Biosciences Inc	Protein production method
KR101439195B1 (ko)	2013-04-18	2014-09-12	동아대학교 산학협력단	에셰리키아 콜리 a-53 균주를 이용하여 섬유소 분해효소의 생산성을 향상시키는 공정
US11390663B2 (en)	2013-10-11	2022-07-19	Regeneron Pharmaceuticals, Inc.	Metabolically optimized cell culture
DK3351620T3 (da) *	2013-10-11	2020-10-26	Regeneron Pharma	Metabolsk optimeret cellekultur
WO2015116820A1 (fr)	2014-01-30	2015-08-06	Coherus Biosciences, Inc.	Milieux de perfusion
EP3102589A1 (fr)	2014-02-04	2016-12-14	Biogen MA Inc.	Chromatographie par échange cationique utilisée dans le mode de fixation par écoulement pour enrichir les modifications post-traductionnelles
PL3227454T3 (pl)	2014-12-01	2020-07-27	Amgen Inc.	Sposób manipulowania poziomem zawartości glikanów w glikoproteinie
KR102007930B1 (ko)	2014-12-31	2019-08-06	주식회사 엘지화학	재조합 당단백질의 글리코실화 조절 방법
CN105777897A (zh) *	2015-03-20	2016-07-20	广东东阳光药业有限公司	一种cho细胞收获液的前处理方法
KR20240093910A (ko) *	2015-04-01	2024-06-24	베링거 인겔하임 인터내셔날 게엠베하	세포 배양 배지
KR101936049B1 (ko) *	2015-10-15	2019-01-08	(주)알테오젠	IgG Fc 도메인을 가지는 융합 단백질의 생산방법
ES3064802T3 (en)	2016-10-21	2026-04-29	Amgen Inc	Pharmaceutical formulations and methods of making the same
GB201708655D0 (en)	2017-05-31	2017-07-12	Ucb Biopharma Sprl	Cell culture methods
CN110484487A (zh) *	2019-08-21	2019-11-22	安徽欣乐生物技术有限公司	一种适用于cho细胞培养用无蛋白培养基及其培养方法
JP2024503239A (ja)	2020-12-22	2024-01-25	アムジェンインコーポレイテッド	細胞培養法
CN115073607A (zh) *	2021-03-12	2022-09-20	上海康岱生物医药技术股份有限公司	Tnfr2与baff受体的融合蛋白
CN114480492B (zh) *	2022-01-28	2023-04-21	景泽生物医药(合肥)股份有限公司	一种重组人抗体融合蛋白的制备方法
CN119510778A (zh) *	2024-12-31	2025-02-25	北京同立海源生物科技有限公司	一种高稳定性的pdgf-bb活性检测方法

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4399216A (en)	1980-02-25	1983-08-16	The Trustees Of Columbia University	Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4522811A (en)	1982-07-08	1985-06-11	Syntex (U.S.A.) Inc.	Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU2353384A (en)	1983-01-19	1984-07-26	Genentech Inc.	Amplification in eukaryotic host cells
US4713339A (en)	1983-01-19	1987-12-15	Genentech, Inc.	Polycistronic expression vector construction
GB8308235D0 (en)	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
JPS6147500A (ja)	1984-08-15	1986-03-07	Res Dev Corp Of Japan	キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (fr)	1984-08-27	1987-11-25	The Board Of Trustees Of The Leland Stanford Junior University	Récepteurs chimériques par liaison et expression de l'ADN
GB8422238D0 (en)	1984-09-03	1984-10-10	Neuberger M S	Chimeric proteins
US5672502A (en)	1985-06-28	1997-09-30	Celltech Therapeutics Limited	Animal cell culture
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
US6048728A (en)	1988-09-23	2000-04-11	Chiron Corporation	Cell culture medium for enhanced cell growth, culture longevity, and product expression
DE68925971T2 (de) *	1988-09-23	1996-09-05	Cetus Oncology Corp	Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US6291159B1 (en)	1989-05-16	2001-09-18	Scripps Research Institute	Method for producing polymers having a preselected activity
US5395760A (en)	1989-09-05	1995-03-07	Immunex Corporation	DNA encoding tumor necrosis factor-α and -β receptors
US5605690A (en)	1989-09-05	1997-02-25	Immunex Corporation	Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
NZ235148A (en)	1989-09-05	1991-12-23	Immunex Corp	Tumour necrosis factor receptor protein and dna sequences
JPH0396383A (ja)	1989-09-08	1991-04-22	Riso Kagaku Corp	画像形成装置
DE59010908D1 (de)	1989-09-12	2000-08-10	Hoffmann La Roche	TNF-bindende Proteine
ES2118066T3 (es)	1989-10-05	1998-09-16	Optein Inc	Sintesis y aislamiento, exentos de celulas, de nuevos genes y polipeptidos.
US6657103B1 (en)	1990-01-12	2003-12-02	Abgenix, Inc.	Human antibodies derived from immunized xenomice
US5538983A (en)	1990-05-16	1996-07-23	The Rockefeller University	Method of treating amyloidosis by modulation of calcium
US5156964A (en)	1990-08-16	1992-10-20	Cetus Corporation	Methods for adapting cells for increased product production through exposure to ammonia
US5122469A (en) *	1990-10-03	1992-06-16	Genentech, Inc.	Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9021679D0 (en)	1990-10-05	1990-11-21	Gorman Scott David	Antibody preparation
GB9022545D0 (en)	1990-10-17	1990-11-28	Wellcome Found	Culture medium
GB2251249B (en)	1990-12-28	1995-06-21	Mogam Biotech Res Inst	High-density medium for animal cell culture
GB9118664D0 (en) *	1991-08-30	1991-10-16	Celltech Ltd	Cell culture
US5447851B1 (en)	1992-04-02	1999-07-06	Univ Texas System Board Of	Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
JP3504963B2 (ja)	1993-10-22	2004-03-08	智靖羅	抗ヒト高親和性ＩｇＥ受容体モノクローナル抗体に係るアミノ酸配列をコードするＤＮＡ断片
US6310185B1 (en)	1994-03-08	2001-10-30	Memorial Sloan Kettering Cancer Center	Recombinant human anti-Lewis Y antibodies
US5856179A (en)	1994-03-10	1999-01-05	Genentech, Inc.	Polypeptide production in animal cell culture
US5589154A (en)	1994-11-22	1996-12-31	Rutgers, The State University Of New Jersey	Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease
IL117175A (en) *	1995-02-20	2005-11-20	Sankyo Co	Osteoclastogenesis inhibitory factor protein
US5705364A (en)	1995-06-06	1998-01-06	Genentech, Inc.	Mammalian cell culture process
US6656466B1 (en) *	1995-06-06	2003-12-02	Genetech, Inc.	Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
US5721121A (en)	1995-06-06	1998-02-24	Genentech, Inc.	Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
JP4306813B2 (ja)	1995-09-19	2009-08-05	アスビオファーマ株式会社	動物細胞の新規培養方法
US20020012991A1 (en) *	1997-04-07	2002-01-31	Florence Chua Nee Ho Kit Fong	Cell culture media for enhanced protein production
US7964192B1 (en)	1997-12-02	2011-06-21	Janssen Alzheimer Immunotherapy	Prevention and treatment of amyloidgenic disease
CA2354862A1 (fr)	1998-10-19	2000-04-27	Yeda Research And Development Co. Ltd.	Traitement du lupus erythemateux systemique par regulation negative de la reponse auto-immune a des autoantigenes
TWI255272B (en)	2000-12-06	2006-05-21	Guriq Basi	Humanized antibodies that recognize beta amyloid peptide
TWI329129B (en)	2001-02-08	2010-08-21	Wyeth Corp	Modified and stabilized gdf propeptides and uses thereof
ES2312569T3 (es)	2001-04-30	2009-03-01	Eli Lilly And Company	Anticuerpos humanizados.
ES2318006T3 (es)	2001-04-30	2009-05-01	Eli Lilly And Company	Anticuerpos humanizados que reconocen el peptido beta-amiloide.
WO2002101019A2 (fr)	2001-06-13	2002-12-19	Genentech, Inc.	Procedes de mise en culture de cellules animales et production de polypeptides dans des cellules animales
US7320789B2 (en)	2001-09-26	2008-01-22	Wyeth	Antibody inhibitors of GDF-8 and uses thereof
JP4429728B2 (ja)	2002-02-21	2010-03-10	ワイスエルエルシー	フォリスタチン（ｆｏｌｌｉｓｔａｔｉｎ）ドメイン含有タンパク質
BR0307907A2 (pt)	2002-02-21	2011-07-05	Wyeth Corp	gasp1: proteìna contendo domìnio de folistatina
MY139983A (en)	2002-03-12	2009-11-30	Janssen Alzheimer Immunotherap	Humanized antibodies that recognize beta amyloid peptide
SG187991A1 (en)	2002-05-02	2013-03-28	Wyeth Corp	Calicheamicin derivative-carrier conjugates
US7261893B2 (en)	2002-10-22	2007-08-28	Wyeth	Neutralizing antibodies against GDF-8 and uses therefor
US20040223966A1 (en)	2002-10-25	2004-11-11	Wolfman Neil M.	ActRIIB fusion polypeptides and uses therefor
TWI384069B (zh)	2004-08-27	2013-02-01	Pfizer Ireland Pharmaceuticals	多胜肽之製法
TWI374935B (en)	2004-08-27	2012-10-21	Pfizer Ireland Pharmaceuticals	Production of α-abeta

2005
- 2005-08-25 US US11/213,633 patent/US7300773B2/en not_active Expired - Lifetime
- 2005-08-25 TW TW094129077A patent/TWI364458B/zh not_active IP Right Cessation
- 2005-08-26 EP EP08005732A patent/EP1992697B1/fr not_active Revoked
- 2005-08-26 EP EP05791482A patent/EP1781802B1/fr not_active Revoked
- 2005-08-26 AT AT05791482T patent/ATE446376T1/de active
- 2005-08-26 DK DK08005732.6T patent/DK1992697T3/da active
- 2005-08-26 PT PT08005732T patent/PT1992697E/pt unknown
- 2005-08-26 DE DE602005020076T patent/DE602005020076D1/de not_active Expired - Lifetime
- 2005-08-26 PE PE2009001227A patent/PE20100448A1/es active IP Right Grant
- 2005-08-26 PL PL05791482T patent/PL1781802T3/pl unknown
- 2005-08-26 HN HN2005000485A patent/HN2005000485A/es unknown
- 2005-08-26 RS RSP-2010/0190A patent/RS51255B/sr unknown
- 2005-08-26 ES ES08005732T patent/ES2341390T3/es not_active Expired - Lifetime
- 2005-08-26 NZ NZ579208A patent/NZ579208A/en not_active IP Right Cessation
- 2005-08-26 PL PL08005732T patent/PL1992697T3/pl unknown
- 2005-08-26 AR ARP050103596A patent/AR050537A1/es not_active Application Discontinuation
- 2005-08-26 GT GT200500233A patent/GT200500233A/es unknown
- 2005-08-26 ES ES05791482T patent/ES2335518T3/es not_active Expired - Lifetime
- 2005-08-26 DE DE602005017285T patent/DE602005017285D1/de not_active Expired - Lifetime
- 2005-08-26 AU AU2005280036A patent/AU2005280036B2/en not_active Expired
- 2005-08-26 CA CA2578138A patent/CA2578138C/fr not_active Expired - Lifetime
- 2005-08-26 WO PCT/US2005/030439 patent/WO2006026447A2/fr not_active Ceased
- 2005-08-26 AT AT08005732T patent/ATE461285T1/de active
- 2005-08-26 BR BRPI0514694A patent/BRPI0514694B8/pt active IP Right Grant
- 2005-08-26 KR KR1020077004810A patent/KR100988451B1/ko not_active Expired - Lifetime
- 2005-08-26 JP JP2007530167A patent/JP2008511330A/ja active Pending
- 2005-08-26 UA UAA200703287A patent/UA89383C2/ru unknown
- 2005-08-26 GT GT200500234A patent/GT200500234A/es unknown
- 2005-08-26 SI SI200530984T patent/SI1992697T1/sl unknown
- 2005-08-26 RU RU2007108717/10A patent/RU2458988C2/ru active
- 2005-08-26 RS RSP-2009/0575A patent/RS51072B/sr unknown
- 2005-08-26 SV SV2005002211A patent/SV2006002211A/es unknown
- 2005-08-26 SI SI200530874T patent/SI1781802T1/sl unknown
- 2005-08-26 MX MX2007002381A patent/MX2007002381A/es active IP Right Grant
- 2005-08-26 DK DK05791482.2T patent/DK1781802T3/da active
- 2005-08-26 CN CN2005800369388A patent/CN101061231B/zh not_active Expired - Fee Related
- 2005-08-26 PT PT05791482T patent/PT1781802E/pt unknown
- 2005-08-26 CN CN2012102771283A patent/CN102876761A/zh active Pending
- 2005-08-26 PE PE2005000987A patent/PE20060815A1/es not_active Application Discontinuation
- 2005-08-26 MY MYPI20054023A patent/MY137803A/en unknown
- 2005-08-26 HR HR20100011T patent/HRP20100011T1/hr unknown
2007
- 2007-02-26 ZA ZA2007/01672A patent/ZA200701672B/en unknown
- 2007-02-27 EG EGNA2007000222 patent/EG26922A/xx active
- 2007-02-27 IL IL181588A patent/IL181588A/en unknown
- 2007-03-16 CR CR8998A patent/CR8998A/es unknown
- 2007-03-26 NO NO20071570A patent/NO344785B1/no not_active IP Right Cessation
- 2007-03-27 EC EC2007007354A patent/ECSP077354A/es unknown
2010
- 2010-01-08 CY CY20101100022T patent/CY1109721T1/el unknown
- 2010-05-14 HR HR20100271T patent/HRP20100271T1/hr unknown
- 2010-06-16 CY CY20101100556T patent/CY1110092T1/el unknown
2012
- 2012-02-17 JP JP2012033112A patent/JP5921910B2/ja not_active Expired - Lifetime
- 2012-11-01 CR CR20120560A patent/CR20120560A/es unknown
- 2012-11-09 AR ARP120104234A patent/AR088824A2/es not_active Application Discontinuation
2016
- 2016-01-28 JP JP2016014650A patent/JP2016056214A/ja active Pending
2017
- 2017-03-09 CL CL2017000577A patent/CL2017000577A1/es unknown

Also Published As

Publication number	Publication date
HK1121497A1 (en)	2009-04-24
CR20120560A (es)	2012-12-04
ECSP077354A (es)	2007-05-30
ES2341390T3 (es)	2010-06-18
UA89383C2 (ru)	2010-01-25
CR8998A (es)	2007-11-23
EP1781802B1 (fr)	2009-10-21
HN2005000485A (es)	2009-06-09
HK1099941A1 (en)	2007-08-31
DE602005020076D1 (de)	2010-04-29
WO2006026447A3 (fr)	2006-04-20
BRPI0514694B1 (pt)	2019-04-24
NZ579208A (en)	2012-01-12
IL181588A0 (en)	2007-07-04
BRPI0514694A (pt)	2008-06-17
PL1992697T3 (pl)	2010-08-31
HRP20100011T1 (hr)	2010-02-28
US20060121569A1 (en)	2006-06-08
CY1110092T1 (el)	2015-01-14
ZA200701672B (en)	2012-04-24
TW200619388A (en)	2006-06-16
DK1992697T3 (da)	2010-05-17
KR100988451B1 (ko)	2010-10-18
WO2006026447A2 (fr)	2006-03-09
GT200500234A (es)	2006-10-10
HRP20100271T1 (hr)	2010-06-30
CL2017000577A1 (es)	2017-12-01
GT200500233A (es)	2006-03-09
PE20060815A1 (es)	2006-09-14
RU2458988C2 (ru)	2012-08-20
PT1781802E (pt)	2010-01-04
TWI364458B (en)	2012-05-21
NO344785B1 (no)	2020-04-27
CA2578138A1 (fr)	2006-03-09
RS51072B (sr)	2010-10-31
JP2012095672A (ja)	2012-05-24
CN101061231B (zh)	2012-09-26
IL181588A (en)	2010-12-30
CA2578138C (fr)	2010-10-05
AU2005280036A1 (en)	2006-03-09
SI1992697T1 (sl)	2010-07-30
SI1781802T1 (sl)	2010-01-29
AU2005280036B2 (en)	2011-11-03
PE20100448A1 (es)	2010-06-22
JP5921910B2 (ja)	2016-05-24
ATE446376T1 (de)	2009-11-15
CN102876761A (zh)	2013-01-16
SV2006002211A (es)	2006-10-04
PT1992697E (pt)	2010-04-21
EP1781802A2 (fr)	2007-05-09
ATE461285T1 (de)	2010-04-15
ES2335518T3 (es)	2010-03-29
RS51255B (sr)	2010-12-31
US7300773B2 (en)	2007-11-27
PL1781802T3 (pl)	2010-03-31
EP1992697A1 (fr)	2008-11-19
BRPI0514694B8 (pt)	2021-05-25
AR050537A1 (es)	2006-11-01
CN101061231A (zh)	2007-10-24
MX2007002381A (es)	2007-06-15
AR088824A2 (es)	2014-07-10
JP2008511330A (ja)	2008-04-17
DK1781802T3 (da)	2010-01-25
CY1109721T1 (el)	2014-08-13
RU2007108717A (ru)	2008-10-10
EP1992697B1 (fr)	2010-03-17
KR20070069140A (ko)	2007-07-02
WO2006026447A9 (fr)	2006-06-01
JP2016056214A (ja)	2016-04-21
MY137803A (en)	2009-03-31
DE602005017285D1 (fr)	2009-12-03
NO20071570L (no)	2007-05-23

Publication	Publication Date	Title
EG26921A (en)	2014-12-23	Salts of mineral nutrients stabilized with amino acids and/or ammonium salts, products and food supplements that contain them and methods for obtaining them
EP2022034A4 (fr)	2014-05-14	Procédé et système d'évaluation, de notation, de groupage et de présentation d'information de valeur nutritionnelle de produits alimentaires
IL182113A0 (en)	2007-07-24	Protein system and food products including same
SG144045A1 (en)	2008-07-29	Aerated food products and methods for producing them
EP2084972A4 (fr)	2014-04-16	Produit alimentaire de substitution de viande et procédé de préparation
WO2008043076A3 (fr)	2008-06-05	Utilisation d'un ph faible pour modifier la texture de produits à base de protéines végétales structurées
PL2178385T3 (pl)	2012-12-31	Termostabilny napój odżywczy i sposób jego wytwarzania
BRPI0717041B8 (pt)	2016-03-01	produto alimentício gaseificado, e, método para preparar o mesmo
IL182814A0 (en)	2007-08-19	Nutrition bar or other food product and peocess of making
WO2008120726A1 (fr)	2008-10-09	Amplificateur de goût salé, aliment et boisson et procédé de préparation d'un aliment et d'une boisson
PT2077076T (pt)	2017-02-14	Composição de aditivo para alimentos compostos para ruminantes e processo de produção da mesma
EP1758464A4 (fr)	2012-10-24	Aliment nutritionnel, composition, traitement et procede d'utilisation
ZA200603592B (en)	2007-01-31	Container for food products and method for transporting food products
ZA200902294B (en)	2010-04-28	Method for obtaining variants of lactic bacteria useful in the production of K2 vitamin and applications for the preparation of food products
PL1688042T3 (pl)	2014-12-31	Sposób i urządzenie do magazynowania, przetwarzania i wydawania artykułów spożywczych
EP1848290A4 (fr)	2008-06-18	Compositions et procedes pour la supplementation nutritionnelle
PL1912520T3 (pl)	2020-07-13	Konserwant i dodatek do żywności i paszy
GB0604647D0 (en)	2006-04-19	Stabilized food supplements and their derivatives
ZA200902524B (en)	2010-01-27	Method and apparatus for the preparation of a reconstituted food product
PL2091359T3 (pl)	2012-02-29	Koncentrat bulionu albo przyprawy i sposób jego wytwarzania
IL213414A0 (en)	2011-07-31	Method for prolonging the shelf of agricultural and food products
BR112013000739A2 (pt)	2016-06-07	"produto de protéina de soja, primeiro produto de proteína de soja, alimento, bebida, ração animal, método para aprimorar a eficácia de secagem de um produto de proteína de soja e método preparação de um produto de proteína de soja "
PL2234503T3 (pl)	2012-01-31	Produkt spożywczy ze stabilizowanym aminokwasem niebiałkowym
PL1871178T3 (pl)	2013-07-31	Nieleczniczy dodatek do żywności dla zwierząt, suplementowana żywność zawierająca ten dodatek i sposób zwiększania wzrostu zwierząt
PL1955596T3 (pl)	2015-08-31	Sposób otrzymywania wędzonych produktów spożywczych ze znakami i produkt tak uzyskany